Retatrutide + Cagrilintide Blend (5mg + 5mg)

(Research Use Only)

This blend combines Retatrutide and Cagrilintide, two synthetic peptides, supplied together as a sterile lyophilized powder (5 mg + 5 mg per vial) for use as a reference material in laboratory, in-vitro, and analytical studies conducted by qualified professionals in appropriately equipped research facilities. This product is not a drug and is not intended for human or veterinary use, clinical applications, or any form of in-vivo administration.

Structural Information

Retatrutide is a synthetic peptide described in the scientific literature as an agonist at glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. Cagrilintide is a synthetic, long-acting analogue of amylin, described as an agonist at amylin and calcitonin receptors. In research settings the two are examined for receptor pharmacology, peptide–receptor binding, and downstream signaling pathways under controlled experimental conditions.

Intended Use and Limitations

This product is supplied for Research Use Only (RUO) and is not intended for human or animal consumption. It must not be used for diagnosis, treatment, cure, or prevention of any disease and must not be compounded, ingested, injected, or otherwise administered to humans or animals. Any scientific literature or background information associated with Retatrutide or Cagrilintide is provided solely to describe their chemical and research characteristics and should not be interpreted as guidance for clinical use or any health outcome.

Handling, Storage, and Quality

Handle using standard laboratory practices appropriate for peptide reference materials, including suitable personal protective equipment and controlled laboratory conditions. Store the lyophilized powder sealed, protected from light and moisture, at the temperature recommended for peptide reference materials. Each vial is supplied with a purity exceeding 99%; batch documentation is available on request.